Literature DB >> 25616474

Topography of brain glucose hypometabolism and epileptic network in glucose transporter 1 deficiency.

Cigdem Inan Akman1, Frank Provenzano2, Dong Wang3, Kristin Engelstad3, Veronica Hinton3, Julia Yu3, Ronald Tikofsky2, Masonari Ichese2, Darryl C De Vivo3.   

Abstract

RATIONALE: (18)F fluorodeoxyglucose positron emission tomography ((18)F FDG-PET) facilitates examination of glucose metabolism. Previously, we described regional cerebral glucose hypometabolism using (18)F FDG-PET in patients with Glucose transporter 1 Deficiency Syndrome (Glut1 DS). We now expand this observation in Glut1 DS using quantitative image analysis to identify the epileptic network based on the regional distribution of glucose hypometabolism.
METHODS: (18)F FDG-PET scans of 16 Glut1 DS patients and 7 healthy participants were examined using Statistical parametric Mapping (SPM). Summed images were preprocessed for statistical analysis using MATLAB 7.1 and SPM 2 software. Region of interest (ROI) analysis was performed to validate SPM results.
RESULTS: Visual analysis of the (18)F FDG-PET images demonstrated prominent regional glucose hypometabolism in the thalamus, neocortical regions and cerebellum bilaterally. Group comparison using SPM analysis confirmed that the regional distribution of glucose hypo-metabolism was present in thalamus, cerebellum, temporal cortex and central lobule. Two mildly affected patients without epilepsy had hypometabolism in cerebellum, inferior frontal cortex, and temporal lobe, but not thalamus. Glucose hypometabolism did not correlate with age at the time of PET imaging, head circumference, CSF glucose concentration at the time of diagnosis, RBC glucose uptake, or CNS score.
CONCLUSION: Quantitative analysis of (18)F FDG-PET imaging in Glut1 DS patients confirmed that hypometabolism was present symmetrically in thalamus, cerebellum, frontal and temporal cortex. The hypometabolism in thalamus correlated with the clinical history of epilepsy.
Copyright © 2014. Published by Elsevier B.V.

Entities:  

Keywords:  Brain glucose metabolism; Glucose transporter deficiency; Positron emission tomography; Statistical parametric mapping

Mesh:

Substances:

Year:  2014        PMID: 25616474     DOI: 10.1016/j.eplepsyres.2014.11.007

Source DB:  PubMed          Journal:  Epilepsy Res        ISSN: 0920-1211            Impact factor:   3.045


  10 in total

1.  CoQ10 Deficiency Is Not a Common Finding in GLUT1 Deficiency Syndrome.

Authors:  Emanuele Barca; Maoxue Tang; Giulio Kleiner; Kristin Engelstad; Salvatore DiMauro; Catarina M Quinzii; Darryl C De Vivo
Journal:  JIMD Rep       Date:  2015-11-29

2.  Disrupted structural and functional rich club organization of the brain connectome in patients with generalized tonic-clonic seizure.

Authors:  Rong Li; Wei Liao; Yibo Li; Yangyang Yu; Zhiqiang Zhang; Guangming Lu; Huafu Chen
Journal:  Hum Brain Mapp       Date:  2016-07-28       Impact factor: 5.038

Review 3.  Glucose transporters in brain in health and disease.

Authors:  Hermann Koepsell
Journal:  Pflugers Arch       Date:  2020-08-13       Impact factor: 3.657

4.  Brain correlates of spike and wave discharges in GLUT1 deficiency syndrome.

Authors:  Anna Elisabetta Vaudano; Sara Olivotto; Andrea Ruggieri; Giuliana Gessaroli; Valentina De Giorgis; Antonia Parmeggiani; Pierangelo Veggiotti; Stefano Meletti
Journal:  Neuroimage Clin       Date:  2016-12-21       Impact factor: 4.881

5.  Brain microvasculature defects and Glut1 deficiency syndrome averted by early repletion of the glucose transporter-1 protein.

Authors:  Maoxue Tang; Guangping Gao; Carlos B Rueda; Hang Yu; David N Thibodeaux; Tomoyuki Awano; Kristin M Engelstad; Maria-Jose Sanchez-Quintero; Hong Yang; Fanghua Li; Huapeng Li; Qin Su; Kara E Shetler; Lynne Jones; Ryan Seo; Jonathan McConathy; Elizabeth M Hillman; Jeffrey L Noebels; Darryl C De Vivo; Umrao R Monani
Journal:  Nat Commun       Date:  2017-01-20       Impact factor: 14.919

6.  A new mouse model of GLUT1 deficiency syndrome exhibits abnormal sleep-wake patterns and alterations of glucose kinetics in the brain.

Authors:  Tamio Furuse; Hiroshi Mizuma; Yuuki Hirose; Tomoko Kushida; Ikuko Yamada; Ikuo Miura; Hiroshi Masuya; Hiromasa Funato; Masashi Yanagisawa; Hirotaka Onoe; Shigeharu Wakana
Journal:  Dis Model Mech       Date:  2019-09-12       Impact factor: 5.758

Review 7.  Therapeutic strategies for glucose transporter 1 deficiency syndrome.

Authors:  Maoxue Tang; Sarah H Park; Darryl C De Vivo; Umrao R Monani
Journal:  Ann Clin Transl Neurol       Date:  2019-08-28       Impact factor: 4.511

8.  Prolonged culturing of iPSC-derived brain endothelial-like cells is associated with quiescence, downregulation of glycolysis, and resistance to disruption by an Alzheimer's brain milieu.

Authors:  Lindsey M Williams; Takashi Fujimoto; Riley R Weaver; Aric F Logsdon; Kira M Evitts; Jessica E Young; William A Banks; Michelle A Erickson
Journal:  Fluids Barriers CNS       Date:  2022-02-05

Review 9.  Mechanisms of Transcranial Magnetic Stimulation Treating on Post-stroke Depression.

Authors:  Xiaoqin Duan; Gang Yao; Zhongliang Liu; Ranji Cui; Wei Yang
Journal:  Front Hum Neurosci       Date:  2018-05-30       Impact factor: 3.169

10.  The effect of chronic neuroglycopenia on resting state networks in GLUT1 syndrome across the lifespan.

Authors:  Anna Elisabetta Vaudano; Sara Olivotto; Andrea Ruggieri; Giuliana Gessaroli; Francesca Talami; Antonia Parmeggiani; Valentina De Giorgis; Pierangelo Veggiotti; Stefano Meletti
Journal:  Hum Brain Mapp       Date:  2019-11-11       Impact factor: 5.038

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.